AHA Coding Clinic® for ICD-9 - 2010 Issue 2; Ask the Editor
Chemotherapy and Dihydropyrimidine Dehydrogenase Deficiency (DPD)
A patient with colon cancer status post resection was admitted with relentless chemo-induced diarrhea following a recent course of 5-fluorouracil (5-FU) chemotherapy. The patient was found to be deficient in an enzyme which metabolizes 5-FU, and the provider diagnosed dihydropyrimidine dehydrogenase (DPD) deficiency. What is the appropriate code assignment for DPD deficiency? ...
Subscribe or sign in to view the full article.
Article Overview
This article explains a coding scenario involving a patient with colon cancer who developed severe diarrhea after chemotherapy and was diagnosed with dihydropyrimidine dehydrogenase (DPD) deficiency. It is aimed at coders handling oncology-related diagnosis coding, external cause coding, and metabolic deficiency questions. The discussion centers on how the diagnosis is categorized and what code set considerations are implicated in the scenario.
Why This Topic Matters
Chemotherapy complications and rare enzyme deficiencies can affect diagnosis assignment and code selection in oncology-related claims. Understanding how this topic is addressed helps coders evaluate similar post-treatment complication scenarios accurately.
What You Will Learn
- How the article frames a chemotherapy-associated complication scenario
- How DPD deficiency is categorized for coding purposes
- Which diagnosis and external-cause code sets are implicated in the example
- How oncology-related complication cases are approached at a high level
Who Should Read This
- Medical coders
- Coding auditors
- Revenue cycle staff
- Oncology documentation specialists
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com